Biological and clinical relevance of stem cells in pancreatic adenocarcinoma

作者: Zeshaan A Rasheed , William Matsui

DOI: 10.1111/J.1440-1746.2011.07015.X

关键词:

摘要: Cancer stem cells (CSC) have been identified in a growing number of human malignancies. CSC are functionally defined by their ability to self-renew and recapitulate tumors the ectopic setting, studies shown that they display other functional characteristics, such as invasion drug resistance. These unique properties implicate role for clinical consequences, initial tumor formation, relapse following treatment, metastasis, resistance, suggesting major factor directing outcomes. Pancreatic adenocarcinoma is highly-aggressive disease with propensity early metastasis Tumorigenic pancreatic cancer using cell surface antigens CD44, CD24, CD133, well high expression aldehyde dehydrogenase (ALDH). In vitro vivo ALDH- CD133-expressing greater ALDH-expressing be resistant conventional chemotherapy. samples from patients resected adenocarcinoma, presence was associated worse overall survival. The development CSC-targeting therapies might important changing outcomes this disease, others we begun identify novel compounds block function. This review will discuss biological relevance cancer, therapeutic strategies target them.

参考文章(39)
Glen J. Weiss, Mitesh J. Borad, Christine L. Hann, Julie R. Brahmer, Howard M. Mackey, Bertram L. Lum, Walter C. Darbonne, James C. Marsters, Frederic J. de Sauvage, Jennifer A. Low, Daniel D. Von Hoff, Patricia M. LoRusso, Charles M. Rudin, Josina C. Reddy, Robert L. Yauch, Raoul Tibes, Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma New England Journal of Medicine. ,vol. 361, pp. 1164- 1172 ,(2009) , 10.1056/NEJMOA0905360
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine, SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma Cell Stem Cell. ,vol. 4, pp. 440- 452 ,(2009) , 10.1016/J.STEM.2009.03.003
Tobias Schatton, George F. Murphy, Natasha Y. Frank, Kazuhiro Yamaura, Ana Maria Waaga-Gasser, Martin Gasser, Qian Zhan, Stefan Jordan, Lyn M. Duncan, Carsten Weishaupt, Robert C. Fuhlbrigge, Thomas S. Kupper, Mohamed H. Sayegh, Markus H. Frank, Identification of cells initiating human melanomas Nature. ,vol. 451, pp. 345- 349 ,(2008) , 10.1038/NATURE06489
Michael F Clarke, John E Dick, Peter B Dirks, Connie J Eaves, Catriona HM Jamieson, D Leanne Jones, Jane Visvader, Irving L Weissman, Geoffrey M Wahl, None, Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research. ,vol. 66, pp. 9339- 9344 ,(2006) , 10.1158/0008-5472.CAN-06-3126
Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke, Jeremy A. Squire, Jane Bayani, Takuichiro Hide, R. Mark Henkelman, Michael D. Cusimano, Peter B. Dirks, Identification of human brain tumour initiating cells Nature. ,vol. 432, pp. 396- 401 ,(2004) , 10.1038/NATURE03128
Ting Li, Yun Su, Yuping Mei, Qixin Leng, Bingjie Leng, Zhenqiu Liu, Sanford A Stass, Feng Jiang, ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Laboratory Investigation. ,vol. 90, pp. 234- 244 ,(2010) , 10.1038/LABINVEST.2009.127
R. W. Storms, A. P. Trujillo, J. B. Springer, L. Shah, O. M. Colvin, S. M. Ludeman, C. Smith, Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 9118- 9123 ,(1999) , 10.1073/PNAS.96.16.9118
Michael P. Kim, Jason B. Fleming, Huamin Wang, James L. Abbruzzese, Woonyoung Choi, Scott Kopetz, David J. McConkey, Douglas B. Evans, Gary E. Gallick, ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma PLoS ONE. ,vol. 6, pp. e20636- ,(2011) , 10.1371/JOURNAL.PONE.0020636
Chenwei Li, David G. Heidt, Piero Dalerba, Charles F. Burant, Lanjing Zhang, Volkan Adsay, Max Wicha, Michael F. Clarke, Diane M. Simeone, Identification of Pancreatic Cancer Stem Cells Cancer Research. ,vol. 67, pp. 1030- 1037 ,(2007) , 10.1158/0008-5472.CAN-06-2030
Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, Florence Monville, Julie Dutcher, Marty Brown, Jocelyne Jacquemier, Patrice Viens, Celina G. Kleer, Suling Liu, Anne Schott, Dan Hayes, Daniel Birnbaum, Max S. Wicha, Gabriela Dontu, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell. ,vol. 1, pp. 555- 567 ,(2007) , 10.1016/J.STEM.2007.08.014